VEGFA and hereditary elliptocytosis: Based on physiological, pharmacological and biochemical observations from proof-of-concept experiments using an in vitro model of HE and corroboratory experiments employing an animal model of HE, the present study demonstrated that VEGF plays a protective role against high fatality associated with HE.